Trial
NCT02624258
Pilot Study of Non-Viral, RNA-Redirected Autologous T Cells in Patients With Refractory or Relapsed Hodgkin Lymphoma
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
Children's Hospital of Philadelphia
Condition
Hodgkin Lymphoma
Intervention
CD19 RNA redirected autologous T-cells (RNA CART19 cells)
Why stopped
Principal Investigator decision to stop trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-21